589 related articles for article (PubMed ID: 31681327)
21. Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.
Lee GR
Mediators Inflamm; 2017; 2017():5458178. PubMed ID: 29463952
[TBL] [Abstract][Full Text] [Related]
22. Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.
Li Y; Wang Z; Lin H; Wang L; Chen X; Liu Q; Zuo Q; Hu J; Wang H; Guo J; Xie L; Tang J; Li Z; Hu L; Xu L; Zhou X; Ye L; Huang Q; Xu L
Front Immunol; 2020; 11():806. PubMed ID: 32477338
[TBL] [Abstract][Full Text] [Related]
23. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.
Li C; Jiang P; Wei S; Xu X; Wang J
Mol Cancer; 2020 Jul; 19(1):116. PubMed ID: 32680511
[TBL] [Abstract][Full Text] [Related]
24. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
25. Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
Solis-Castillo LA; Garcia-Romo GS; Diaz-Rodriguez A; Reyes-Hernandez D; Tellez-Rivera E; Rosales-Garcia VH; Mendez-Cruz AR; Jimenez-Flores JR; Villafana-Vazquez VH; Pedroza-Gonzalez A
Breast Cancer; 2020 Sep; 27(5):837-849. PubMed ID: 32180141
[TBL] [Abstract][Full Text] [Related]
26. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.
Watson MJ; Vignali PDA; Mullett SJ; Overacre-Delgoffe AE; Peralta RM; Grebinoski S; Menk AV; Rittenhouse NL; DePeaux K; Whetstone RD; Vignali DAA; Hand TW; Poholek AC; Morrison BM; Rothstein JD; Wendell SG; Delgoffe GM
Nature; 2021 Mar; 591(7851):645-651. PubMed ID: 33589820
[TBL] [Abstract][Full Text] [Related]
27. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment.
Scott EN; Gocher AM; Workman CJ; Vignali DAA
Front Immunol; 2021; 12():702726. PubMed ID: 34177968
[TBL] [Abstract][Full Text] [Related]
29. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
[TBL] [Abstract][Full Text] [Related]
30. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells.
Wang HY; Peng G; Guo Z; Shevach EM; Wang RF
J Immunol; 2005 Mar; 174(5):2661-70. PubMed ID: 15728473
[TBL] [Abstract][Full Text] [Related]
31. Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.
Pires A; Greenshields-Watson A; Jones E; Smart K; Lauder SN; Somerville M; Milutinovic S; Kendrick H; Hindley JP; French R; Smalley MJ; Watkins WJ; Andrews R; Godkin A; Gallimore A
Cancer Immunol Res; 2020 Dec; 8(12):1520-1531. PubMed ID: 33023965
[TBL] [Abstract][Full Text] [Related]
32. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
33. The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment.
Ducimetière L; Vermeer M; Tugues S
Front Immunol; 2019; 10():2895. PubMed ID: 31921156
[TBL] [Abstract][Full Text] [Related]
34. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
35. Induced regulatory T cells in inhibitory microenvironments created by cancer.
Whiteside TL
Expert Opin Biol Ther; 2014 Oct; 14(10):1411-25. PubMed ID: 24934899
[TBL] [Abstract][Full Text] [Related]
36. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
Luo CT; Liao W; Dadi S; Toure A; Li MO
Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
[TBL] [Abstract][Full Text] [Related]
37. Regulation of regulatory T cells in cancer.
Stockis J; Roychoudhuri R; Halim TYF
Immunology; 2019 Jul; 157(3):219-231. PubMed ID: 31032905
[TBL] [Abstract][Full Text] [Related]
38. The Intersection between Tumor Angiogenesis and Immune Suppression.
Rahma OE; Hodi FS
Clin Cancer Res; 2019 Sep; 25(18):5449-5457. PubMed ID: 30944124
[TBL] [Abstract][Full Text] [Related]
39. Treg-mediated acquired resistance to immune checkpoint inhibitors.
Saleh R; Elkord E
Cancer Lett; 2019 Aug; 457():168-179. PubMed ID: 31078738
[TBL] [Abstract][Full Text] [Related]
40. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.
Pedros C; Canonigo-Balancio AJ; Kong KF; Altman A
JCI Insight; 2017 Dec; 2(23):. PubMed ID: 29212947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]